Kendra Wong
Comptroller/Controller/Auditor bij LENSAR, INC.
Vermogen: 123 892 $ op 30-04-2024
Profiel
Kendra W.
Wong is currently working as the Principal Accounting Officer at LENSAR, Inc. She previously worked as the Assistant Controller-Subsidiary Operations at PDL BioPharma, Inc. from 2018 to 2021.
Ms. Wong holds an MBA from Arizona State University and an undergraduate degree from the University of California, Davis.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LENSAR INC
0.32% | 06-05-2024 | 36 120 ( 0.32% ) | 123 892 $ | 30-04-2024 |
Actieve functies van Kendra Wong
| Bedrijven | Functie | Begin |
|---|---|---|
| LENSAR, INC. | Comptroller/Controller/Auditor | 11-01-2022 |
Eerdere bekende functies van Kendra Wong
| Bedrijven | Functie | Einde |
|---|---|---|
| PDL BIOPHARMA, INC. | Corporate Officer/Principal | 01-03-2021 |
Opleiding van Kendra Wong
| University of California, Davis | Undergraduate Degree |
| Arizona State University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LENSAR, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
